Early intensive therapy in type 2 diabetes may preserve beta cell function

By mdCurrent-India staff | Published: Sep 2012 Volume: 1.

mdCurrent Conference Report: 72^nd annual scientific sessions of the American Diabetes Association

Intensive therapy initiated in newly diagnosed patients with type 2 diabetes preserved beta-cell function over the course of a 3.5-year study.

The study’s lead investigator, Ildiko Lingvay, MD, recommended that “we try to achieve glycemic normalization as quickly as possible after diagnosis. Additionally, I recommend we maintain...

LECTURE: Managing Transitional Cell Carcinoma of the Bladder…

This entry was posted in Diabetes, Primary Care and tagged 72nd annual scientific sessions of the american diabetes association, ADA, american diabetes association, antidiabetes, beta cell, beta cell function, diabetes, diabetes mellitus, Diabetes Therapy, glucose control, glyburide, hypoglycemia, insulin, intensive glucose control, internal medicine, metformin, pioglitazone, primary care, type 2 diabetes. Volume: 1.

Post a Comment Cancel reply

Logged In

» Log in

» Modify Profile (update email, etc.)

» Forgot Your Password?
Follow mdCurrent-India for the latest health news!

» Register for Free for full access
Reading Recommendations:

© 2012 - 2023 mdCurrent, LLC. All rights reserved. Most of the content on this site is professional in nature and is intended for physicians, except for the patient education section. All content is for informational purposes only, and it is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. ISSN 2572-343X

indicates a Peer-Reviewed Article

Early intensive therapy in type 2 diabetes may preserve beta cell function

Related Posts:

Post a Comment Cancel reply

Minimally Invasive Surgeries

Interesting Reads

More >>

Logged In

Reading Recommendations: